Dr Lalchandani Labs
15.58
-15.58(-100.00%)
Market Cap₹13.50 Cr
PE Ratio32.46
Company Performance:
1D-100.00%
1M-100.00%
6M-100.00%
1Y-100.00%
5Y-100.00%
View Company Insightsright
More news about Dr Lalchandani Labs
20Jan 26
Dr Lalchandani Labs Approves ₹4.33 Crore Rights Issue with 1:1 Entitlement Ratio
Dr Lalchandani Labs Limited approved a rights issue of 43.32 lakh equity shares at ₹10 per share, totaling ₹4.33 crores. The 1:1 entitlement ratio allows existing shareholders to purchase one new share for every share held as of January 27, 2026 record date. The issue opens February 4, 2026 and closes February 20, 2026, potentially doubling outstanding shares to 86.65 lakh upon full subscription.
 no imag found
16Jan 26
Dr Lalchandani Labs Receives BSE In-Principle Approval for Rights Issue
Dr Lalchandani Labs has received BSE in-principle approval for its proposed rights issue worth ₹433.31 lakhs through reference number LOD/Rights/RB/FIP/1544/2025-26 dated January 16, 2026. The approval permits the company to proceed with issuing fully paid-up equity shares with face value of ₹10 each to eligible shareholders, subject to compliance with statutory requirements and post-issue formalities.
 no imag found
05Sept 25
Dr Lalchandani Labs Appoints New Independent Director and Expands Authorized Capital
Dr Lalchandani Labs Limited has announced key corporate developments following a board meeting. The company appointed Mr. Mohan Lal Gandhi as a Non-Executive Independent Director for a five-year term. The board also approved an increase in authorized capital from Rs. 4.50 crore to Rs. 11.00 crore. The company's 8th Annual General Meeting is scheduled for September 30, 2025, in New Delhi. M/s. Chauhan Pradeep & Associates has been appointed as Secretarial Auditors for a five-year term and as the scrutinizer for the upcoming AGM.
 no imag found
Dr Lalchandani Labs
15.58
-15.58
(-100.00%)
1 Year Returns:-100.00%
Industry Peers
Dr. Lal Path Labs
1,355.10
(-1.59%)
Metropolis Healthcare
1,808.60
(-0.84%)
Krsnaa Diagnostics
603.65
(-1.33%)
Suraksha Diagnostic
259.85
(+1.01%)
3B BlackBio DX
1,187.85
(-2.25%)
Sastasundar Ventures
281.00
(-0.35%)